Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Zender

Showing results (41-50 of 192) with videos related to

Pageof 20
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 23, 2016
C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trialRoland Syha, Sergios Gatidis, Gerd Grözinger, et al.
Nature Reviews. Cancer|May 31, 2023
Advances in PET imaging of cancerJohannes Schwenck, Dominik Sonanini, Jonathan M Cotton, et al.
Journal of Medicinal Chemistry|May 6, 2026
Darizmetinib (HRX215): A Promising 1st-in-Class Liver Regenerating Drug in Phase 1b/2a Clinical Development, Targeting the Stress Signaling Protein Kinase MKK4Wolfgang Albrecht, Roland Selig, Bent Pfaffenrot, et al.
RNA (New York, N.Y.)|February 28, 2014
Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma developmentAsaf Shilo, Vered Ben Hur, Polina Denichenko, et al.
The Journal of Experimental Medicine|January 25, 2012
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progressionRamona Schulz, Natalia D Marchenko, Lena Holembowski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2010
Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunityEngin Gürlevik, Norman Woller, Nina Strüver, et al.
World Journal of Surgical Oncology|January 8, 2025
SarkoLife: quality of life in patients undergoing multimodal soft tissue sarcoma treatmentSebastian Hoffmann, Tabea Hoffmann, Vlatko Potkrajcic, et al.
Cancer Research|June 18, 2003
A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancerThomas Wirth, Lars Zender, Bernd Schulte, et al.
Nature|January 26, 2007
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasWen Xue, Lars Zender, Cornelius Miething, et al.
Digestive Diseases and Sciences|February 12, 2002
p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosisStefan Kubicka, Christiane Claas, Sven Staab, et al.
Pageof 20

Showing results (41-50 of 192) with videos related to

Sort By:
Pageof 20
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 23, 2016
C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trialRoland Syha, Sergios Gatidis, Gerd Grözinger, et al.
Nature Reviews. Cancer|May 31, 2023
Advances in PET imaging of cancerJohannes Schwenck, Dominik Sonanini, Jonathan M Cotton, et al.
Journal of Medicinal Chemistry|May 6, 2026
Darizmetinib (HRX215): A Promising 1st-in-Class Liver Regenerating Drug in Phase 1b/2a Clinical Development, Targeting the Stress Signaling Protein Kinase MKK4Wolfgang Albrecht, Roland Selig, Bent Pfaffenrot, et al.
RNA (New York, N.Y.)|February 28, 2014
Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma developmentAsaf Shilo, Vered Ben Hur, Polina Denichenko, et al.
The Journal of Experimental Medicine|January 25, 2012
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progressionRamona Schulz, Natalia D Marchenko, Lena Holembowski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2010
Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunityEngin Gürlevik, Norman Woller, Nina Strüver, et al.
World Journal of Surgical Oncology|January 8, 2025
SarkoLife: quality of life in patients undergoing multimodal soft tissue sarcoma treatmentSebastian Hoffmann, Tabea Hoffmann, Vlatko Potkrajcic, et al.
Cancer Research|June 18, 2003
A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancerThomas Wirth, Lars Zender, Bernd Schulte, et al.
Nature|January 26, 2007
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasWen Xue, Lars Zender, Cornelius Miething, et al.
Digestive Diseases and Sciences|February 12, 2002
p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosisStefan Kubicka, Christiane Claas, Sven Staab, et al.
Pageof 20